NCT03031119 - Multiple Ascending Dose and DDI Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

Placebo

Tablets administered once or twice daily, with food, in Part A.

DRUG

PF-06835919

Tablets administered once or twice daily, with food, in Part A. Tablets administered once or twice daily, with food and atorvastatin in Part B.

DRUG

atorvastatin

In Part B, tablets administered once or twice daily, with food, with and without PF-06835919.

Trial Locations (1)

Pfizer Clinical Research Unit, Brussels